Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2000
03/23/2000WO1999052892A3 Novel herbicides
03/22/2000EP0987266A1 Biphenyl derivatives and medicinal compositions
03/22/2000EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones
03/22/2000EP0986562A1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
03/22/2000EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000CN1248259A Condensed pyridazing derivatives, their production and use
03/22/2000CN1248258A Method for producing heteroaromatic alcohols free of enantiomers
03/22/2000CN1248244A N-arylsulfonamide- and pyrrolidinecarboxylic acid intermediates, and their use for preparation of herbicidal 1,3-dioxo-1H-pyrrolo [1,2-c] imidazole derivatives
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040442 Process for preparing 1,2,5-thiadiazole containing ethers
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/16/2000WO2000014088A1 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
03/16/2000WO2000013508A1 Fused-benzene derivatives useful as herbicides
03/16/2000WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/16/2000WO1999065910A9 Fused azepinone cyclin dependent kinase inhibitors
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000DE19841948A1 Cage molecules with controllable sorption-desorption properties comprise coronand systems made up of triazine rings linked by chalcogen-chalcogen or chalcogen-metal-chalcogen bridging groups
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0984692A1 Novel angiogenesis inhibitors
03/15/2000EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
03/15/2000CN1247572A Method for producing esters free of enantiomers
03/15/2000CN1247571A Method for producing alcohols free of enantiomers
03/15/2000CN1247542A Serine protease inhibitors
03/15/2000CN1247025A Fungicide mixture
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/09/2000WO2000013015A1 Modulating multiple lineage kinase proteins
03/09/2000WO2000012632A1 Process for the preparation of substituted amido phthalocyanine derivatives and substituted amido phthalocyanine derivatives
03/09/2000WO2000012515A1 Vinyl substituted cyclic products of the ene-yne reaction
03/09/2000WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
03/09/2000WO2000012511A1 Imidazotriazolopyrimidines
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012509A2 Collections of compounds
03/09/2000WO2000012508A2 Pyrrolbenzodiazepines
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012505A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
03/09/2000WO2000012504A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000005230A8 Pyrazole derivatives and salts thereof
03/09/2000DE19840608A1 Metallierte oder unmetallierte Phthalocyanine Metal or unmetallated phthalocyanines
03/09/2000DE19840289A1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2342109A1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000CA2341716A1 Vinyl substituted cyclic products of the ene-yne reaction
03/09/2000CA2341452A1 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
03/09/2000CA2341386A1 Collections of compounds
03/09/2000CA2340129A1 Process for the preparation of substituted amido phthalocyanine derivatives and substituted amido phthalocyanine derivatives
03/09/2000CA2339539A1 Modulating multiple lineage kinase proteins
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0984041A2 Metallised or metal-free phthalocyanine
03/08/2000EP0984015A1 Improved synthesis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo (5.5.0.05,9,03,11) dodecane
03/08/2000EP0984008A2 Nitrosation process
03/08/2000EP0983274A1 Phthalocyanine and use of phthalocyanine as a marking agent
03/08/2000EP0983273A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
03/08/2000EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds
03/08/2000EP0983248A1 Analogs of duocarmycin and cc-1065
03/08/2000EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0983068A1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
03/08/2000EP0854857B1 Method of preparing optically active alpha-amino acids and alpha-amino acid derivatives
03/08/2000EP0591355B1 Porphycene compounds for photodynamic therapy
03/08/2000CN1246886A 荧光主－客体系统 Fluorescent host - guest system
03/08/2000CN1246885A Fluorescent materials and their use
03/08/2000CN1246860A 3-aryl substituted pyrazolo [4,3-d] pyrimidine derivatives, corticotropin-releasing factor receptor (CRT1) specific ligands
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246478A Process for preparing Xidinafei
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them
03/07/2000US6034236 Reacting a phthalonitrile with a metal oxide in presence of a sulfonic acid catalyst
03/02/2000WO2000011041A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent
03/02/2000WO2000011005A1 Process for the synthesis of triazolopyridazine compounds
03/02/2000WO2000011004A1 Process for the preparation of pyrrolo[2,3-d]pyrimidines
03/02/2000WO2000011001A1 Muscarinic agonists and antagonists
03/02/2000WO2000010983A1 Process for preparing regiospecific substituted pyrazine isomers
03/02/2000WO2000010979A1 Process for preparing piperazic acid and its conversion to n-acylated bicyclic rings containing n,n-linkages useful as intermediates for caspase inhibitors
03/02/2000WO2000010964A1 Photoactivatable bases containing nitrogen
03/02/2000WO2000010565A1 Growth hormone secretagogues
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000DE19838705A1 Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one New dihydro- (1,2,3) triazolo [4,5-d] pyrimidin-7-one
03/02/2000DE19814405C2 Porphyrine und ihre Verwendung als Photosensitizer Porphyrins and their use as photosensitizer
03/02/2000CA2340946A1 Muscarinic agonists and antagonists
03/02/2000CA2340250A1 Process for preparing regiospecific substituted pyrazine isomers
03/02/2000CA2338945A1 Process for the preparation of pyrrolo¬2,3-d|pyrimidines
03/02/2000CA2337428A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 573